MMC vs PLRX · P/E 22, rev $24.46B vs $77.3M cap
Marsh & McLennan Companies Inc (MMC) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the MMC and PLRX stock pages for the full models.
Not investment advice.